The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Solid Biosciences Inc (NASDAQ: SLDB) closed at $4.51 in the last session, down -1.53% from day before closing price of $4.58. In other words, the price has decreased by -$1.53 from its previous closing price. On the day, 1.23 million shares were traded.
Ratios:
We take a closer look at SLDB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.89 and its Current Ratio is at 10.89. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on January 08, 2025, initiated with a Buy rating and assigned the stock a target price of $16.
On December 13, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $16.
On December 10, 2024, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $15.JMP Securities initiated its Mkt Outperform rating on December 10, 2024, with a $15 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 11 ’25 when Kahn Clare bought 1,860 shares for $5.34 per share. The transaction valued at 9,924 led to the insider holds 2,960 shares of the business.
Bain Capital Life Sciences Inv bought 1,000,000 shares of SLDB for $4,030,000 on Feb 19 ’25. The 10% Owner now owns 5,034,582 shares after completing the transaction at $4.03 per share. On Feb 19 ’25, another insider, PERCEPTIVE ADVISORS LLC, who serves as the Director of the company, bought 5,000,000 shares for $4.03 each. As a result, the insider paid 20,150,000 and bolstered with 11,833,539 shares of the company.
Stock Price History:
Over the past 52 weeks, SLDB has reached a high of $10.37, while it has fallen to a 52-week low of $2.41. The 50-Day Moving Average of the stock is 37.12%, while the 200-Day Moving Average is calculated to be -7.08%.
Shares Statistics:
A total of 77.49M shares are outstanding, with a floating share count of 56.60M. Insiders hold about 26.98% of the company’s shares, while institutions hold 77.15% stake in the company.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 10.0 analysts currently analyzing and rating the stock of Solid Biosciences Inc (SLDB).The consensus estimate for the next quarter is -$0.5, with high estimates of -$0.43 and low estimates of -$0.6.
Analysts are recommending an EPS of between -$1.82 and -$2.83 for the fiscal current year, implying an average EPS of -$2.14. EPS for the following year is -$2.11, with 9.0 analysts recommending between -$1.39 and -$2.68.
